Bureau for Cancer Research
New York, New York 10032
0 studies enrolling now ยท 1 studies all time
What they study most
FGFR2 Amplification, Metastatic Gastric Cancer, PD-L1 Gene Amplification
Studies at this site
- Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer โ Status unconfirmed